These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33207917)

  • 1. Sialic acid-based strategies for the prevention and treatment of
    Sun X; Zhang S; Ren J; Udenigwe CC
    Crit Rev Food Sci Nutr; 2022; 62(7):1713-1724. PubMed ID: 33207917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice.
    Yang JC; Shun CT; Chien CT; Wang TH
    J Nutr; 2008 Nov; 138(11):2084-90. PubMed ID: 18936202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysaccharides as Bacterial Antiadhesive Agents and "Smart" Constituents for Improved Drug Delivery Systems Against Helicobacter pylori Infection.
    Menchicchi B; Hensel A; Goycoolea FM
    Curr Pharm Des; 2015; 21(33):4888-906. PubMed ID: 26290206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces boulardii expresses neuraminidase activity selective for α2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells.
    Sakarya S; Gunay N
    APMIS; 2014 Oct; 122(10):941-50. PubMed ID: 24628732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion of Helicobacter pylori strains to alpha-2,3-linked sialic acids.
    Hirmo S; Kelm S; Schauer R; Nilsson B; Wadström T
    Glycoconj J; 1996 Dec; 13(6):1005-11. PubMed ID: 8981092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice.
    Henriques PC; Costa LM; Seabra CL; Antunes B; Silva-Carvalho R; Junqueira-Neto S; Maia AF; Oliveira P; Magalhães A; Reis CA; Gartner F; Touati E; Gomes J; Costa P; Martins MCL; Gonçalves IC
    Acta Biomater; 2020 Sep; 114():206-220. PubMed ID: 32622054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy.
    Im BN; Shin H; Lim B; Lee J; Kim KS; Park JM; Na K
    Biomaterials; 2021 Apr; 271():120745. PubMed ID: 33740616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and Helicobacter pylori infection in children.
    Lionetti E; Francavilla R; Castellazzi AM; Arrigo T; Labò E; Leonardi S; Ciprandi G; Miraglia Del Giudice M; Salpietro V; Salpietro C; La Rosa M
    J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S69-76. PubMed ID: 22691253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
    Gonçalves IC; Henriques PC; Seabra CL; Martins MC
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 11. A new approach for the prevention and treatment of Helicobacter pylori infection via upregulation of autophagy and downregulation of apoptosis.
    Yang JC; Chien CT
    Autophagy; 2009 Apr; 5(3):413-4. PubMed ID: 19197143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori resistance to current therapies.
    Smith SM; O'Morain C; McNamara D
    Curr Opin Gastroenterol; 2019 Jan; 35(1):6-13. PubMed ID: 30489412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials.
    Ohishi T; Inaoka DK; Kita K; Kawada M
    Chem Pharm Bull (Tokyo); 2018; 66(3):239-242. PubMed ID: 29491257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for the prevention and treatment of Helicobacter pylori infection.
    Ruggiero P; Peppoloni S; Berti D; Rappuoli R; Giudice GD
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1127-38. PubMed ID: 12150706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem.
    Hu Y; Zhang M; Lu B; Dai J
    Helicobacter; 2016 Oct; 21(5):349-63. PubMed ID: 26822340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products and food components with anti-Helicobacter pylori activities.
    Takeuchi H; Trang VT; Morimoto N; Nishida Y; Matsumura Y; Sugiura T
    World J Gastroenterol; 2014 Jul; 20(27):8971-8. PubMed ID: 25083070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of
    de Souza MPC; de Camargo BAF; Spósito L; Fortunato GC; Carvalho GC; Marena GD; Meneguin AB; Bauab TM; Chorilli M
    Crit Rev Microbiol; 2021 Aug; 47(4):435-460. PubMed ID: 33725462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
    Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomaterials for
    Lai Y; Wei W; Du Y; Gao J; Li Z
    Gut Microbes; 2022; 14(1):2120747. PubMed ID: 36070564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.